What is Currently Recommended?
Two serogroup B meningococcal (MenB) vaccines are currently licensed for use among persons aged 10–25 years in the United States: MenB-FHbp (Trumenba) and MenB-4C (Bexsero). The Advisory Committee on Immunization Practices (ACIP) and CDC currently recommends routine use of MenB vaccines among persons aged ≥10 years who are at increased risk for serogroup B meningococcal disease (Category A recommendation), including persons who have persistent complement component deficiencies; persons who have anatomic or functional asplenia; microbiologists who routinely are exposed to isolates of Neisseria meningitidis; and persons identified to be at increased risk because of a serogroup B meningococcal disease outbreak.
The ACIP and CDC recommends all adolescents and young adults aged 16–23 years may be vaccinated with MenB vaccines to provide protection against serogroup B meningococcal disease (Category B recommendation).
Source: Patton ME, Stephens D, Moore K, MacNeil JR. Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep 2017;66:509–513. DOI: LINK.
- The Centers for Disease Control and Surveillance (CDC) is a U.S. government agency that provides up-to-date and detailed information on meningococcal disease and vaccination for healthcare professionals as well as for children and families. This includes package inserts for the vaccines Bexsero, and Trumenba.
- The Immunization Action Coalition has vaccine information statements about meningococcal types ACWY vaccine and type B vaccine.
- The American Academy of Pediatrics (AAP) is a professional organization that aims to achieve optimal health and well-being for infants, children, adolescents and young adults. The AAP published this 2016 policy statement with recommendations on serogroup B meningococcal vaccination.
- The National Meningitis Association (NMA) provides education to the public and to healthcare professionals about meningococcal disease. The NMA provides support to families affected by meningococcal disease. The NMA also provides state-by-state information on meningococcal disease vaccine requirements.